Component
Mouse plasma GLP-1 response
Mouse plasma GLP-1 response. Interpret through the linked study species, preparation, exposure and measured endpoint.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Oral AITC raised GLP-1 in both wild-type and Trpa1-null mice; the response was not reduced by Trpa1 loss.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_condition
- AITC in wild-type mice deleted · Mouse Trpa1 ion channel Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- AITC in wild-type mice administered · Allyl isothiocyanate / AITC Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "AITC in Trpa1-null mice", "comparator": "AITC in wild-type mice", "endpoint": "Oral AITC raised GLP-1 in both wild-type and Trpa1-null mice; the response was not reduced by Trpa1 loss.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "allyl-isothiocyanate", "state": "administered"}, {"entity_slug": "mouse-trpa1", "state": "deleted"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Mouse oral AITC 15 mg/kg; plasma measurement at five minutes.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- The null concerns genotype effect; AITC increased GLP-1 versus vehicle. Does not prove TRPA1 mediation in vivo.
- plain_language
- Oral AITC raised GLP-1 in both wild-type and Trpa1-null mice; the response was not reduced by Trpa1 loss.
- primary_references
- Stimulation of GLP-1 secretion downstream of the ligand-gated ion channel TRPA1. | 2015 | DOI 10.2337/db14-0737 | PMID 25325736 | https://pubmed.ncbi.nlm.nih.gov/25325736/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4375100/ | https://doi.org/10.2337/db14-0737
- source_locator
- Reviewed reference lines 75-75; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 75–75
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse oral AITC 15 mg/kg; plasma measurement at five minutes. · Recorded from source · Recorded from source
**The GLP-1 experiment did not test allicin.** Allyl isothiocyanate (AITC) and carvacrol increased calcium signaling and GLP-1 secretion in mouse intestinal cultures; antagonism or Trpa1 deletion limited those responses. Glucose-induced responses persisted during TRPA1 blockade. In vivo, oral AITC at 15 mg/kg raised GLP-1 even in Trpa1-null mice; lower doses did not significantly increase it. Capsaicin did not increase secretion in the tested cultures. These findings constrain a proposed allicin–TRPA1–GLP-1 connection, but they do not demonstrate it. AITC is not allicin. [Emery 2015](https://pmc.ncbi.nlm.nih.gov/articles/PMC4375100/)
Complete structured claim and evidenceLower oral AITC doses did not significantly increase plasma GLP-1 in the tested mice.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_contrast
- {"intervention": "Lower-dose AITC", "comparator": "Vehicle", "endpoint": "Lower oral AITC doses did not significantly increase plasma GLP-1 in the tested mice.", "effect_direction": "no_detected_change", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Mouse oral 0.15 and 1.5 mg/kg AITC; five-minute measurement.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- AITC-specific short-term null; no allicin conclusion.
- plain_language
- Lower oral AITC doses did not significantly increase plasma GLP-1 in the tested mice.
- primary_references
- Stimulation of GLP-1 secretion downstream of the ligand-gated ion channel TRPA1. | 2015 | DOI 10.2337/db14-0737 | PMID 25325736 | https://pubmed.ncbi.nlm.nih.gov/25325736/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4375100/ | https://doi.org/10.2337/db14-0737
- source_locator
- Reviewed reference lines 75-75; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 75–75
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse oral 0.15 and 1.5 mg/kg AITC; five-minute measurement. · Recorded from source · Recorded from source
**The GLP-1 experiment did not test allicin.** Allyl isothiocyanate (AITC) and carvacrol increased calcium signaling and GLP-1 secretion in mouse intestinal cultures; antagonism or Trpa1 deletion limited those responses. Glucose-induced responses persisted during TRPA1 blockade. In vivo, oral AITC at 15 mg/kg raised GLP-1 even in Trpa1-null mice; lower doses did not significantly increase it. Capsaicin did not increase secretion in the tested cultures. These findings constrain a proposed allicin–TRPA1–GLP-1 connection, but they do not demonstrate it. AITC is not allicin. [Emery 2015](https://pmc.ncbi.nlm.nih.gov/articles/PMC4375100/)
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.